Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
1-A
1-A POS
1-A-W
1-A/A
1-K
1-K/A
1-SA
1-SA/A
1-U
1-U/A
1-Z
1-Z-W
1-Z/A
1/A
10-12B
10-12B/A
10-12G
10-12G/A
10-D
10-D/A
10-K
10-K/A
10-K405
10-K405/A
10-KT
10-KT/A
10-Q
10-Q/A
10-QSB
10-QSB/A
10-QT
10-QT/A
10KSB
11-K
11-K/A
11-KT
13F-HR
13F-HR/A
13F-NT
13F-NT/A
13FCONP
144
144/A
15-12B
15-12B/A
15-12G
15-12G/A
15-15D
15-15D/A
15F-12B
15F-12G
15F-12G/A
15F-15D
18-K
18-K/A
19B-4E
2-E
20-F
20-F/A
20FR12B
20FR12B/A
20FR12G/A
24F-2NT
24F-2NT/A
25
25-NSE
25-NSE/A
25/A
253G1
253G2
253G3
3
3/A
305B2
305B2/A
4
4/A
40-17F1
40-17F1/A
40-17F2
40-17F2/A
40-17G
40-17G/A
40-202A
40-202A/A
40-206A
40-24B2
40-33
40-6B
40-6B/A
40-6C
40-6C/A
40-8B25
40-8F-2/A
40-APP
40-APP/A
40-F
40-F/A
40-OIP
40-OIP/A
40FR12B
40FR12B/A
424B1
424B2
424B3
424B4
424B5
424B7
424B8
424H
424H/A
425
485APOS
485B24E
485BPOS
485BXT
486APOS
486BPOS
486BXT
487
497
497AD
497J
497K
5
5/A
6-K
6-K/A
8-A12B
8-A12B/A
8-A12G
8-A12G/A
8-K
8-K/A
8-K12B
8-K12B/A
8-K12G3
8-K12G3/A
8-K15D5
8-K15D5/A
8-M
9-M
ABS-15G
ABS-15G/A
ABS-EE
ABS-EE/A
ADV-E
ADV-H-C
ADV-H-T
ADV-NR
ANNLRPT
APP NTC
APP ORDR
APP WD
APP WD/A
ARS
ARS/A
ATS-N
ATS-N/CA
ATS-N/MA
ATS-N/UA
AW
AW WD
C
C-AR
C-AR-W
C-AR/A
C-TR
C-U
C-U-W
C-W
C/A
C/A-W
CB
CB/A
CERT
CERTARCA
CERTBATS
CERTCBO
CERTNAS
CERTNYS
CERTPAC
CFPORTAL
CFPORTAL/A
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEF13E3
DEF13E3/A
DEFA14A
DEFA14C
DEFC14A
DEFC14A
DEFC14C
DEFM14A
DEFM14C
DEFN14A
DEFR14A
DEFR14C
DEFS14A
DEFS14C
DEL AM
DFAN14A
DFRN14A
DOS/A
DSTRBRPT
DSTRBRPT/A
EFFECT
F-1
F-1/A
F-10
F-10/A
F-10EF
F-1MEF
F-3
F-3/A
F-3ASR
F-3D
F-4
F-4/A
F-6
F-6 POS
F-6/A
F-6EF
F-7
F-8 POS
F-80
F-N
F-X
F-X/A
FOCUSN
FOCUSN/A
FWP
G-405
G-FIN/A
IRANNOTICE
MA
MA-A
MA-I
MA-I/A
MA-W
MA/A
MSD
MSD/A
N-14
N-14 8C
N-14 8C/A
N-14/A
N-14MEF
N-18F1
N-1A
N-1A/A
N-2
N-2/A
N-23C-2
N-23C3A
N-23C3B
N-2MEF
N-30B-2
N-30D
N-30D/A
N-4
N-4/A
N-54A
N-54C
N-6
N-6/A
N-6F
N-8A
N-8A/A
N-8B-2/A
N-8F
N-8F NTC
N-8F ORDR
N-8F/A
N-CEN
N-CEN/A
N-CSR
N-CSR/A
N-CSRS
N-CSRS/A
N-MFP2
N-MFP2/A
N-PX
N-PX/A
N-Q
N-Q/A
NO ACT
NPORT-P
NPORT-P/A
NRSRO-CE
NRSRO-CE/A
NRSRO-UPD
NSAR-A
NSAR-A/A
NSAR-AT
NSAR-B
NSAR-B/A
NSAR-BT
NSAR-U
NSAR-U/A
NT 10-K
NT 10-K/A
NT 10-Q
NT 10-Q/A
NT 11-K
NT 20-F
NT 20-F/A
NT N-CEN
NT N-MFP2
NT NPORT-EX
NT-NCSR
NT-NCSR/A
NT-NSAR
NT-NSAR/A
NTFNCSR
NTN 10Q
POS 8C
POS AM
POS AMI
POS EX
POS462B
POSASR
PRE 14A
PRE 14C
PREC14A
PREC14C
PREM14A
PREM14C
PREN14A
PRER14A
PRER14C
PRRN14A
PX14A6G
QRTLYRPT
QUALIF
REG-NR
REGDEX
REGDEX/A
REVOKED
RW
RW WD
S-1
S-1/A
S-11
S-11/A
S-11MEF
S-1MEF
S-1MEF
S-3
S-3/A
S-3ASR
S-3D
S-3DPOS
S-3MEF
S-4
S-4 POS
S-4/A
S-4MEF
S-6
S-6/A
S-8
S-8 POS
S-B
S-B/A
SC 13D
SC 13D/A
SC 13E
SC 13E/A
SC 13E1
SC 13E1/A
SC 13E3
SC 13E3/A
SC 13E4
SC 13E4/A
SC 13G
SC 13G/A
SC 14D9
SC 14D9/A
SC 14F1
SC TO-C
SC TO-I
SC TO-I/A
SC TO-T
SC TO-T/A
SC14D9C
SD
SD/A
SDR/A
SE
SEC STAFF
SEC STAFF ACTION
SEC STAFF LETTER
SF-1/A
SF-3
SF-3/A
SUPPL
T-3
T-3/A
TA-1
TA-1/A
TA-2
TA-2/A
TA-W
UPLOAD
WDL-REQ
X-17A-5
X-17A-5/A
Tags
Acq. announced
Inv. presentation
Consulting agrmnt
Quarterly results
CC transcript
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
02/03/2023
8-K
Quarterly results
08/02/2022
8-K
Quarterly results
05/03/2022
8-K
Quarterly results
02/07/2022
8-K
Quarterly results
11/04/2021
8-K
Quarterly results
08/03/2021
8-K
Quarterly results
05/04/2021
8-K
Quarterly results
02/05/2021
8-K
Quarterly results
11/06/2020
8-K
Quarterly results
08/04/2020
8-K
Quarterly results
05/11/2020
8-K
Quarterly results
02/04/2020
8-K
Quarterly results
11/05/2019
8-K
Quarterly results
07/26/2019
8-K
Quarterly results
04/26/2019
8-K
Quarterly results
Docs:
"
RECONCILIATION OF REPORTED NET SALES % CHANGE TO CONSTANT CURRENCY % CHANGE For the Three Months Ended Foreign Constant Exchange Currency % Change Impact % Change Geographic Results Americas % % % EMEA 1.5 Asia Pacific 1.4 5.6 Total % % 0.7 % Product Categories Knees Americas % % % EMEA 1.5 Asia Pacific 1.8 6.8 Total 0.5 Hips Americas 0.1 EMEA 1.7 Asia Pacific 1.9 5.7 Total 1.7 S.E.T 1.7 Spine & CMF 1.7 Dental Other Total % % 0.7 % Page 11 of 17 ZIMMER BIOMET HOLDINGS, INC. RECONCILIATION OF REPORTED TO ADJUSTED RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2019 and 2018 FOR THE THREE MONTHS ENDED MARCH 31, 2019 Cost of products sold, excluding intangible asset amortization Intangible asset amortization Research and development Selling, general and administrative Acquisition, inte...
"
02/01/2019
8-K
Quarterly results
10/26/2018
8-K
Quarterly results
07/27/2018
8-K
Quarterly results
04/26/2018
8-K
Quarterly results
Docs:
"
Net sales of $2.018 billion for the first quarter represent an increase of 2.3% over the prior year period, and a decrease of 1.5% on a constant currency basis • Diluted EPS for the first quarter were $0.85 reported, a decrease of 42.2% from the prior year period • Adjusted diluted EPS for the first quarter were $1.91, a decrease of 10.3% from the prior year period • The Company provides full-year 2018 financial guidance April 26, 2018 — Zimmer Biomet Holdings, Inc. today reported financial results for the quarter ended March 31, 2018. The Company reported first quarter net sales of $2.018 billion, an increase of 2.3% over the prior year period, and a decrease of 1.5% on a constant currency basis. Diluted earnings per share for the first quarter were $0.85, a decrease ...
"
01/30/2018
8-K
Quarterly results
Docs:
"
Net sales of $2.074 billion for the fourth quarter represent an increase of 3.0% over the prior year period, and an increase of 1.5% on a constant currency basis • Diluted EPS for the fourth quarter were $6.16, and include a one-time tax benefit of approximately $6.40 resulting from the recently enacted U.S. tax reform legislation . Fourth quarter adjusted diluted EPS were $2.10, a decrease of 1.9% from the prior year period • The Company provides first quarter 2018 sales and earnings guidance January 30, 2018 — Zimmer Biomet Holdings, Inc. today reported financial results for the quarter and full year ended December 31, 2017. The Company reported fourth quarter net sales of $2.074 billion, an increase of 3.0% over the prior year period, and an increase of 1.5% on a constant ...
"
07/27/2017
8-K
Quarterly results
Docs:
"
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : July 27, 2017 ZIMMER BIOMET HOLDINGS, INC. Delaware 001-16407 13-4151777 File Number) Identification No.) 345 East Main Street Warsaw, Indiana 46580 Registrant's telephone number, including area code: 267-6131 Not applicable
",
"
Zimmer Biomet Reports Second Quarter 2017 Financial Results
"
04/27/2017
8-K
Form 8-K - Current report
01/31/2017
8-K
Form 8-K - Current report
10/31/2016
8-K
Form 8-K - Current report
07/28/2016
8-K
Form 8-K - Current report
04/28/2016
8-K
Form 8-K - Current report
01/28/2016
8-K
Quarterly results
Docs:
"
Zimmer Biomet Holdings, Inc. Reports Fourth Quarter and Full-Year 2015 Financial Results
"
10/29/2015
8-K
Quarterly results
Docs:
"
Zimmer Biomet Holdings, Inc. Reports Third Quarter 2015 Financial Results
",
"
Revised prior period financial statement information
"
07/30/2015
8-K
Quarterly results
Docs:
"
Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results • Net Sales of $1.17 billion represent a decrease of 1.3% reported from the prior year period and an increase of 5.7% constant currency • Reported net loss per share for the second quarter was $, and adjusted earnings per share were $1.59, an increase of 0.6% over the prior year period • Company updates guidance July 30, 2015—Zimmer Biomet Holdings, Inc. today reported financial results for the quarter ended June 30, 2015. The Company reported second quarter net sales of $1.17 billion, a decrease of 1.3% reported and an increase of 5.7% constant currency compared to the second quarter of 2014. Acquired revenue from Biomet amounted to $60 million, a contribution of 5.0% of the constant currency growth rate. Standalon...
"
04/30/2015
8-K
Quarterly results
Docs:
"
Zimmer Holdings, Inc. Reports First Quarter 2015 Financial Results • Net Sales of $1.13 billion represent a decrease of 2.3% reported from the prior year period • Diluted EPS for the first quarter were $1.02 reported, a decrease of 20.9% from the prior year period, and $1.58 adjusted, a decrease of 1.3% from the prior year period • The Company updates full-year adjusted earnings guidance on a standalone basis and expectations for accretion associated with the pending Biomet merger April 30, 2015—Zimmer Holdings, Inc. today reported financial results for the quarter ended March 31, 2015. The Company reported first quarter net sales of $1.13 billion, a decrease of 2.3% reported and an increase of 4.5% constant currency compared to the first quarter of 2014. Diluted earnings per share for the...
"
10/23/2014
8-K
Quarterly results
Docs:
"
Zimmer Holdings, Inc. Reports Third Quarter 2014 Financial Results • Net Sales of $1.11 billion represent an increase of 2.9% reported over the prior year period • Diluted EPS for the Third Quarter were $0.96 reported, an increase of 6.7% over the prior year period, and $1.35 adjusted, an increase of 8.0% over the prior year period • Company updates sales and earnings guidance for full-year 2014 October 23, 2014—Zimmer Holdings, Inc. today reported financial results for the quarter ended September 30, 2014. The Company reported third quarter net sales of $1.11billion, an increase of 2.9% reported and 3.1% constant currency over the third quarter of 2013. Diluted earnings per share for the quarter were $0.96 reported and $1.35 adjusted, an increase of 8.0% adjusted over the prior year perio...
"
07/24/2014
8-K
Quarterly results
Docs:
"
Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results • Net Sales of $1.18 billion represent an increase of 1.2% reported over the prior year period • Diluted EPS for the second quarter were $1.03 reported, an increase of 15.7% over the prior year period, and $1.49 adjusted, an increase of 4.2% over the prior year period • Company updates sales and earnings guidance for full-year 2014 July 24, 2014—Zimmer Holdings, Inc. today reported financial results for the quarter ended June 30, 2014. The Company reported second quarter net sales of $1.18 billion, an increase of 1.2% reported and 0.9% constant currency over the second quarter of 2013. Diluted earnings per share for the quarter were $1.03 reported and $1.49 adjusted, an increase of 4.2% adjusted over the prior year period....
"
04/24/2014
8-K
Quarterly results
Docs:
"
Zimmer Holdings, Inc. Reports First Quarter 2014 Financial Results • Net Sales of $1.161 billion represent an increase of 2.0% reported over the prior year period • Diluted EPS for the first quarter were $1.29 reported, an increase of 0.8% over the prior year period, and $1.50 adjusted, an increase of 6.4% over the prior year period • Company reaffirms sales and updates earnings guidance for 2014 April 24, 2014—Zimmer Holdings, Inc. today reported financial results for the quarter ended March 31, 2014. The Company reported first quarter net sales of $1.161 billion, an increase of 2.0% reported and an increase of 3.2% constant currency over the first quarter of 2013. Diluted earnings per share for the quarter were $1.29 reported and $1.50 adjusted, an increase of 6.4% adjusted over the prio...
"
10/24/2013
8-K
Form 8-K - Current report
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy